Substance Abuse & Addiction
Top Stories
-
Smithers Center at Columbia University Irving Medical Center provides evidence-based care to individuals seeking treatment for substance use disorders and co-occurring mental health conditions.
-
In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
-
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
-
This new series highlights some of the up-and-coming faculty committed to our trifold mission of patient care, medical education, and scientific research.
Latest News
-
Researchers findings at Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute could lead to a new approach to the treatment of alcohol use disorder.
-
"In our participants, ketamine appears to have increased resilience and reduced demoralization after a lapse," Dr. Elias Dakwar said.
-
Dr. Elias Dakwar has conducted laboratory and clinical investigations of ketamine infusion and mindfulness training to treat cocaine use disorder.
-
"The rate at which individuals relapsed and overdosed after ending treatment was alarmingly high, suggesting that discontinuing buprenorphine is a life-threatening event," said Dr. Williams.
-
People with opioid addiction face a high risk of overdose after ending treatment, even when treated for 18 months, a Columbia study has found.
-
Dr. Katherine Elkington, Associate Professor of Clinical Psychology (in Psychiatry) at Columbia University, discusses the complex connection between suicide and substance use in adolescents.
-
Source:
Los Angeles Times
“It’s easy to just take a pill every day,” Dr. Adam Bisaga said. “To come off a drug means you’re going to have to do a lot more work.”
-
Dr. Elias Dakwar sought proof of the suggestion that concentrated doses of ketamine may help reduce vulnerabilities associated with cocaine use, and improve the likelihood of relapse prevention.
-
“As we treat more people with ketamine, an unfortunate side effect of that is more exposure, which means that we're going to create more ketamine addicts,” said Dr. Drew Ramsey.
-
Researchers at Columbia have developed a “Cascade of Care” model for treating individuals with opioid use disorder based on lessons learned in the HIV/AIDS field.
Pages